BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23261103)

  • 1. Esophageal hyperkeratosis after proton pump inhibitor therapy in a patient with esophageal eosinophilia.
    Molina-Infante J; Ferrando-Lamana L; Vinagre-Rodriguez G
    Gastrointest Endosc; 2013 Jan; 77(1):131-2. PubMed ID: 23261103
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus.
    Tanaka K; Toyoda H; Kadowaki S; Hamada Y; Kosaka R; Yamanaka M; Imoto I
    Endoscopy; 2007 Feb; 39 Suppl 1():E105-6. PubMed ID: 17440852
    [No Abstract]   [Full Text] [Related]  

  • 3. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required.
    Lipka S; Muhammad A; Champeaux A; Richter JE
    Dis Esophagus; 2016 Aug; 29(6):700-3. PubMed ID: 24842729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
    Dam C; Bygum A
    Acta Derm Venereol; 2008; 88(1):87-9. PubMed ID: 18176768
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again.
    Hirano I
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):99-101. PubMed ID: 21070874
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophilic esophagitis and proton pump-responsive esophageal eosinophilia: what is in a name?
    Katzka DA
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2023-5. PubMed ID: 25086198
    [No Abstract]   [Full Text] [Related]  

  • 9. Esophageal polyp in a boy with eosinophilic esophagitis.
    Goyal A; Poulik J; Chang CH; El-Baba M
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):541. PubMed ID: 20818263
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
    Emerson CR; Marzella N
    Clin Ther; 2010 Aug; 32(9):1578-96. PubMed ID: 20974316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE-mediated anaphylaxis to proton pump inhibitors - cross-reacting study.
    Vovolis V; Koutsostathis N; Stefanaki E
    Allergy; 2008 Sep; 63(9):1251-2. PubMed ID: 18699945
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic reaction to proton pump ınhibitor: pantoprazole induced Kounis syndrome.
    Canpolat U; Şahiner L; Aytemir K; Oto A
    Int J Cardiol; 2012 Aug; 159(2):e27-8. PubMed ID: 22192298
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypersensitivity to proton pump inhibitors: lansoprazole-induced Kounis syndrome.
    Vlahos NP; Vavilis GK; Giannelou AG; Georgopoulou CN; Kommata VJ; Kougias CT; Tsartsalis DN; Kounis GN; Mazarakis A; Batsolaki M; Gouvelou-Deligianni GV; Hahalis G; Kounis NG
    Int J Cardiol; 2009 May; 134(3):e94-6. PubMed ID: 18378022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps.
    Choi KE; Kim MJ; Lee JH; Lee JS; Lee JH; Choe YH
    Digestion; 2012; 85(3):179-84. PubMed ID: 22248910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT; Chapman W; Neumann CS; Gearty JC
    Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
    Quasdorff M; Mertens J; Dinter J; Steffen HM
    Ann Intern Med; 2011 Sep; 155(6):405-7. PubMed ID: 21930865
    [No Abstract]   [Full Text] [Related]  

  • 18. Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis.
    Sodikoff J; Hirano I
    J Allergy Clin Immunol; 2016 Feb; 137(2):631-3. PubMed ID: 26318073
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
    Dohil R; Newbury R; Fox L; Bastian J; Aceves S
    Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma.
    Sawatzki M; Stienen MN; Straumann A; Meyenberger C; Ohlschlegel C; Binek J
    Gastrointest Endosc; 2012 Sep; 76(3):690-2. PubMed ID: 22154409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.